Fayez Sarofim & CO Organon & Co. Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Organon & Co. stock. As of the latest transaction made, Fayez Sarofim & CO holds 29,799 shares of OGN stock, worth $436,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,799

Previous 24,454 21.86%

Holding current value

$436,257

Previous $506,000 12.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.65 - $23.03 $99,684 - $123,095	5,345 Added 21.86%	29,799 $570,000
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $75,680 - $95,240	4,337 Added 21.56%	24,454 $506,000
Q1 2024 May 14, 2024	SELL	$13.78 - $18.8 $37,164 - $50,703	-2,697 Reduced 11.82%	20,117 $378,000
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $23,728 - $37,532	-2,167 Reduced 8.67%	22,814 $328,000
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $30,857 - $44,212	-1,860 Reduced 6.93%	24,981 $433,000
Q2 2023 Aug 14, 2023	SELL	$19.27 - $24.63 $2.72 Million - $3.47 Million	-140,964 Reduced 84.0%	26,841 $558,000
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $276,746 - $414,473	-12,920 Reduced 7.15%	167,805 $3.95 Million
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $10.1 Million - $12.3 Million	-431,548 Reduced 70.48%	180,725 $5.05 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $26.1 Million - $38.2 Million	-1,116,377 Reduced 64.58%	612,273 $14.3 Million
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $307,798 - $378,185	-9,722 Reduced 0.56%	1,728,650 $58.3 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $295,304 - $381,713	-9,698 Reduced 0.55%	1,738,372 $60.7 Million
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $156,910 - $203,212	-5,473 Reduced 0.31%	1,748,070 $53.2 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $153,886 - $191,565	-5,375 Reduced 0.31%	1,753,543 $57.5 Million
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $50 Million - $66.8 Million	1,758,918 New	1,758,918 $53.2 Million

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.72B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account